Idenix Pharmaceuticals' Corporate Majority Round

Idenix Pharmaceuticals raised a round of funding on May 10, 2003. Investors include Novartis.

Idenix Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix is headquartered in Cambridge, Massachusetts (…

Articles about Idenix Pharmaceuticals' Corporate Majority Round: